搜尋
Quoin Pharmaceuticals Ltd
QNRX添加自選
6.900USD
-0.070-1.00%
收盤 09-10 16:00（美東）
486.44M總市值
虧損本益比TTM
盤後交易 (美東)0.000USD0.000
盤後交易 (美東)關於 Quoin Pharmaceuticals Ltd 公司
Quoin Pharmaceuticals Ltd, former Cellect Biotechnology Ltd, is an Israel-based specialty pharmaceutical company, focused on developing and commercializing therapeutic products that treat rare and orphan diseases. The Company’s first lead product is QRX003, a once daily, topical lotion comprised of a broad-spectrum serine protease inhibitor, formulated with the proprietary Invisicare technology, to treat Netherton Syndrome. The product going to be developed for other rare dermatological diseases including Peeling Skin Syndrome, SAM Syndrome, and Palmoplantar Keratoderma. Quoin is also developing QRX004 as a potential treatment for Dystrophic Epidermolysis Bullosa, and QRX006 as a potential therapy for an, as of yet, undisclosed rare skin disease.
Quoin Pharmaceuticals Ltd 簡介
公司代碼QNRX
公司名稱Quoin Pharmaceuticals Ltd
上市日期Nov 01, 1989
CEOMyers (Michael)
員工數量3
證券類型Depository Receipt
年結日Nov 01
公司地址23 Hata'as Street
城市KFAR SABA
上市交易所NASDAQ OMX - NASDAQ BASIC
國家Israel
郵編44425
電話97299741444
網址https://quoinpharma.com/
公司代碼QNRX
上市日期Nov 01, 1989
CEOMyers (Michael)
Quoin Pharmaceuticals Ltd公司高管
名稱
名稱/職務
職務
持股
持股變動
Dr. Michael Myers, Ph.D.
Dr. Michael Myers, Ph.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
37.71K
+54.33%
Ms. Sally Lawlor
Ms. Sally Lawlor
Chief Financial Officer
Chief Financial Officer
10.68K
+95.88%
Dr. Amotz Nehushtan
Dr. Amotz Nehushtan
Vice President - Research & Development & Product Development
Vice President - Research & Development & Product Development
--
--
Mr. Guy Sapir
Mr. Guy Sapir
Internal Auditor
Internal Auditor
--
--
Dr. Amos Ofer
Dr. Amos Ofer
Chief Operating Officer, Vice President
Chief Operating Officer, Vice President
--
--
Mr. David L. Braun
Mr. David L. Braun
Independent Director
Independent Director
--
--
Mr. Jonathan Burgin, CPA
Mr. Jonathan Burgin, CPA
Independent External Director
Independent External Director
--
--
Ms. Ronit Biran
Ms. Ronit Biran
Independent Director
Independent Director
--
--
Mr. Yali Sheffi
Mr. Yali Sheffi
Independent External Director
Independent External Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Dr. Michael Myers, Ph.D.
Dr. Michael Myers, Ph.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
37.71K
+54.33%
Ms. Sally Lawlor
Ms. Sally Lawlor
Chief Financial Officer
Chief Financial Officer
10.68K
+95.88%
Dr. Amotz Nehushtan
Dr. Amotz Nehushtan
Vice President - Research & Development & Product Development
Vice President - Research & Development & Product Development
--
--
Mr. Guy Sapir
Mr. Guy Sapir
Internal Auditor
Internal Auditor
--
--
Dr. Amos Ofer
Dr. Amos Ofer
Chief Operating Officer, Vice President
Chief Operating Officer, Vice President
--
--
Mr. David L. Braun
Mr. David L. Braun
Independent Director
Independent Director
--
--
常見問題
Quoin Pharmaceuticals Ltd的前五大股東是誰？
Quoin Pharmaceuticals Ltd的前五大股東如下：Dr. Michael Myers, Ph.D.
有多少機構持有Quoin Pharmaceuticals Ltd(QNRX)的股份？
截至2026Q1，共有40家機構持有Quoin Pharmaceuticals Ltd的股份，合計持有的股份價值約為874.98K，占公司總股份的43.66% 。與2025Q4相比，機構持股有所增加，增幅為369388.00。